Generic Name and Formulations:
Guanfacine (as HCl) 1mg, 2mg; tabs.
Promius Pharma, LLC
Indications for TENEX:
Initially 1mg/day at bedtime. May increase to 2mg/day at bedtime; usual max 3mg/day.
Severe coronary insufficiency. Recent MI. Cerebrovascular disease. Chronic renal or hepatic failure. Avoid abrupt cessation. Elderly. Labor & delivery: not recommended for treating hypertension due to pregnancy toxemia. Pregnancy (Cat.B). Nursing mothers.
Central alpha-2 agonist.
Additive sedation with alcohol, other CNS depressants. Caution with microsomal enzyme inducing drugs (eg, barbiturates, phenytoin) in renal impairment.
Dry mouth, somnolence, dizziness, headache, impotence, asthenia, constipation, fatigue.
Tabs 1mg—100, 500; 2mg—100
Endocrinology Advisor Articles
- Cushing Syndrome Results in Poor Quality of Life Even After Remission
- DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes
- Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes
- Nonfunctioning Adrenal Incidentaloma Associated With Metabolic Syndrome
- Low Predictive Power of Biomarkers for Estimated Glomerular Filtration Rate Decline
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Link Between Gestational Diabetes and Risk for CVD and Diabetes in Hispanic/Latina Population
- Clinical Characteristics Altering Risks and Benefits of Sulfonylureas and Thiazolidinedione Therapy in T2D
- 6 Factors Related to Inclusion in Health Care Workplace Identified
- Weight Gain After Quitting Smoking May Increase Risk for T2D